Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Exchange Rate Effect (2016 - 2025)

Dexcom (DXCM) has disclosed Exchange Rate Effect for 13 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 133.93% to $3.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.5 million through Dec 2025, up 390.54% year-over-year, with the annual reading at $21.5 million for FY2025, 390.54% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was $3.8 million at Dexcom, up from -$1.1 million in the prior quarter.
  • The five-year high for Exchange Rate Effect was $16.5 million in Q2 2025, with the low at -$11.2 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is $420000.0, with a median of -$750000.0 recorded in 2021.
  • The sharpest move saw Exchange Rate Effect crashed 960.0% in 2022, then surged 1750.0% in 2025.
  • Over 5 years, Exchange Rate Effect stood at -$500000.0 in 2021, then skyrocketed by 1460.0% to $6.8 million in 2022, then fell by 10.29% to $6.1 million in 2023, then crashed by 283.61% to -$11.2 million in 2024, then surged by 133.93% to $3.8 million in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at $3.8 million, -$1.1 million, and $16.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.